Bavarian Nordic and the US Department of Defense (DoD) have partnered to develop a new prophylactic vaccine for a rare mosquito-borne illness caused by the equine encephalitis virus.
Under the multi-year deal, the DoD will provide funding of about $36m, while Bavarian Nordic will use its MVA-BN platform to formulate a new product that will target different strains of the virus that currently lack preventive therapies.
Go deeper with GlobalData
In preclinical models, an MVA-BN-based vaccine candidate is reported to have demonstrated a positive efficacy profile against three separate equine encephalitis viruses, namely Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV).
The partners plan to conduct additional preclinical studies to aid clinical development, GMP production, and safety and immunogenicity testing in humans.
Bavarian Nordic expects that clinical proof-of-concept data will enable further development of the vaccine candidate with potential follow-on financial support for obtaining FDA licensure and production.
Bavarian Nordic president and CEO Paul Chaplin said: “We are very proud of this alliance which represents yet another public/private engagement between Bavarian Nordic and the US Government, and provides the DoD with the first in what could become a ‘library’ of safe, clinically validated vaccines that are readily accessible and can be deployed as needed.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“This type of collaboration further validates our model for preparedness, which could prove useful in the years to come for this, and potentially other rare and tropical diseases.”
The vaccine is set be available to the DoD for vaccinating individuals who may be deployed in a region considered at high risk for equine encephalitis.
